|
DE34727C
(de)
|
|
|
Ch. H. TH. HAVEMANN in Paris, 16 rue Bleue |
Verfahren zur direkten Gewinnung metallischen Bleis
|
|
DD34727A1
(de)
|
1963-12-21 |
1964-12-28 |
Dietrich Krebs |
Verfahren zur Herstellung von 1-Stellung substituierten [5-Bis-(chloräthyl)-amino-benzimidazolyl-(2)]-alkancarbonsäuren
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US6407079B1
(en)
|
1985-07-03 |
2002-06-18 |
Janssen Pharmaceutica N.V. |
Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
US5369108A
(en)
|
1991-10-04 |
1994-11-29 |
Sloan-Kettering Institute For Cancer Research |
Potent inducers of terminal differentiation and methods of use thereof
|
|
GB9126209D0
(en)
|
1991-12-10 |
1992-02-12 |
Orion Yhtymae Oy |
Drug formulations for parenteral use
|
|
US5602112A
(en)
|
1992-06-19 |
1997-02-11 |
Supergen, Inc. |
Pharmaceutical formulation
|
|
US5882941A
(en)
|
1994-05-04 |
1999-03-16 |
Massachusette Institute Of Technology |
Programmable genotoxic agents and uses therefor
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
US6133248A
(en)
|
1997-06-13 |
2000-10-17 |
Cydex, Inc. |
Polar drug of prodrug compositions with extended shelf-life storage and a method of making thereof
|
|
US6040321A
(en)
|
1997-11-12 |
2000-03-21 |
Bristol-Myers Squibb Company |
Aminothiazole inhibitors of cyclin dependent kinases
|
|
US6214852B1
(en)
|
1998-10-21 |
2001-04-10 |
Bristol-Myers Squibb Company |
N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
|
|
US6392053B2
(en)
|
1999-12-15 |
2002-05-21 |
Bristol-Myers Squibb Company |
Process for preparing arylacetylaminothiazoles
|
|
AU2001273413A1
(en)
|
2000-07-12 |
2002-01-21 |
Immunex Corporation |
Method for treating cancer using an interleukin- 4 antagonist
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
ATE310719T1
(de)
|
2000-09-29 |
2005-12-15 |
Topotarget Uk Ltd |
Carbaminsäurederivate enthaltend eine amidgruppe als hdac-inhibitoren
|
|
WO2002055017A2
(en)
|
2000-11-21 |
2002-07-18 |
Wake Forest University |
Method of treating autoimmune diseases
|
|
CN1764648A
(zh)
|
2003-01-13 |
2006-04-26 |
安斯泰来制药有限公司 |
作为组蛋白脱乙酰酶(hdac)抑制剂的异羟肟酸衍生物
|
|
WO2004076386A2
(en)
|
2003-02-25 |
2004-09-10 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
|
|
US20060270730A1
(en)
|
2003-08-07 |
2006-11-30 |
Andreas Katopodis |
Histone deacetylase inhibitors as immunosuppressants
|
|
US7223745B2
(en)
|
2003-08-14 |
2007-05-29 |
Cephalon, Inc. |
Proteasome inhibitors and methods of using the same
|
|
CA2561617A1
(en)
|
2004-04-05 |
2005-10-20 |
Aton Pharma, Inc. |
Histone deacetylase inhibitor prodrugs
|
|
WO2007134169A2
(en)
|
2006-05-10 |
2007-11-22 |
Nuada, Llc |
Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
|
|
US8436190B2
(en)
|
2005-01-14 |
2013-05-07 |
Cephalon, Inc. |
Bendamustine pharmaceutical compositions
|
|
ATE542527T1
(de)
|
2005-05-13 |
2012-02-15 |
Topotarget Uk Ltd |
Pharmazeutische formulierungen von hdac-hemmern
|
|
US7399956B2
(en)
|
2005-11-28 |
2008-07-15 |
Avago Technologies Ecbuip Pte Ltd |
Optical encoder with sinusoidal photodetector output signal
|
|
UA95310C2
(ru)
|
2006-10-20 |
2011-07-25 |
Айкос Корпорейшен |
Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака
|
|
GB0621160D0
(en)
|
2006-10-24 |
2006-12-06 |
Imp College Innovations Ltd |
Compounds and uses thereof
|
|
TWI519313B
(zh)
|
2006-11-20 |
2016-02-01 |
希佛隆公司 |
使用放射敏感劑放射敏感化腫瘤之方法
|
|
SI2099489T1
(sl)
|
2006-12-11 |
2014-09-30 |
Genentech, Inc. |
Sestavki in postopki za zdravljenje neoplazme
|
|
CN101084876A
(zh)
|
2007-07-11 |
2007-12-12 |
济南康泉医药科技有限公司 |
一种含苯达莫司汀的抗癌组合物
|
|
TW200922564A
(en)
|
2007-09-10 |
2009-06-01 |
Curis Inc |
CDK inhibitors containing a zinc binding moiety
|
|
WO2009067453A1
(en)
|
2007-11-19 |
2009-05-28 |
Syndax Pharmaceuticals, Inc. |
Combinations of hdac inhibitors and proteasome inhibitors
|
|
US8987468B2
(en)
|
2008-02-04 |
2015-03-24 |
The Translational Genomics Research Institute |
Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
|
|
AU2009296734B2
(en)
|
2008-09-25 |
2016-02-18 |
Cephalon Llc |
Liquid formulations of bendamustine
|
|
CA2737495A1
(en)
|
2008-10-08 |
2010-04-15 |
Cephalon, Inc. |
Processes for the preparation of bendamustine
|
|
WO2010075542A1
(en)
|
2008-12-23 |
2010-07-01 |
Curis, Inc. |
Cdk inhibitors
|
|
PL2389375T3
(pl)
|
2009-01-23 |
2015-11-30 |
Euro Celtique Sa |
Pochodne kwasu hydroksamowego
|
|
CN102935080A
(zh)
|
2009-02-25 |
2013-02-20 |
休普拉特克药品有限公司 |
苯达莫司汀环多糖组合物
|
|
US8603521B2
(en)
|
2009-04-17 |
2013-12-10 |
Pharmacyclics, Inc. |
Formulations of histone deacetylase inhibitor and uses thereof
|
|
WO2011017448A1
(en)
|
2009-08-05 |
2011-02-10 |
The Trustees Of The University Of Pennsylvania |
Use of histone deacetylase inhibitors for treatment of autoimmune diseases
|
|
WO2011048661A1
(ja)
|
2009-10-19 |
2011-04-28 |
日立建機株式会社 |
建設機械の診断システム及び診断方法
|
|
CN101928234B
(zh)
|
2010-01-15 |
2012-12-12 |
北京欧凯纳斯科技有限公司 |
6/7-（杂）芳基-n-羟基己/庚酰胺化合物及其制备方法
|
|
EP2558866B1
(en)
|
2010-04-15 |
2016-08-17 |
Tracon Pharmaceuticals, Inc. |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
|
US9889147B2
(en)
|
2010-04-16 |
2018-02-13 |
Cellact Pharma Gmbh |
Analogues of etoposide for the treatment of tumours
|
|
JO3659B1
(ar)
|
2010-06-02 |
2020-08-27 |
Astellas Deutschland Gmbh |
أشكال جرعات بينداموستين عن طريق الفم وإستخداماته العلاجية
|
|
US8748470B2
(en)
|
2011-03-17 |
2014-06-10 |
The University Of Chicago |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
|
|
RU2609833C2
(ru)
|
2011-09-13 |
2017-02-06 |
Фармасайкликс Элэлси |
Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение
|
|
CN102993102B
(zh)
|
2011-09-16 |
2016-08-24 |
杭州民生药业有限公司 |
[1-甲基-2-(7’-庚异羟肟酸基)-5-n，n-二(2’-氯乙基)]-1h-苯并咪唑的合成方法
|
|
EP2758052B9
(en)
|
2011-09-18 |
2019-03-27 |
Euro-Celtique S.A. |
Pharmaceutical composition comprising an HDAC inhibitor and a cyclopolysaccharide
|
|
MX342746B
(es)
|
2011-09-28 |
2016-10-11 |
Euro-Celtique S A * |
Derivados de mostaza de nitrogeno.
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
US10335494B2
(en)
|
2013-12-06 |
2019-07-02 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-CD30 antibodies
|
|
NZ630314A
(en)
|
2014-02-18 |
2016-03-31 |
Celgene Corp |
Combination therapy for hematological malignancies
|
|
GB201409488D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409471D0
(en)
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB201409485D0
(en)
*
|
2014-05-28 |
2014-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
CA2969790A1
(en)
|
2014-12-05 |
2016-06-09 |
University of Modena and Reggio Emilia |
Combinations of histone deacetylase inhibitors and bendamustine
|
|
JP2016109634A
(ja)
|
2014-12-09 |
2016-06-20 |
株式会社安川電機 |
エンコーダ及びエンコーダ付きモータ
|
|
US20180311215A1
(en)
|
2015-10-20 |
2018-11-01 |
Hangzhou TINO Pharma Co., Ltd. |
Pharmaceutical composition and preparation method therefor
|
|
US20180098969A1
(en)
|
2016-10-11 |
2018-04-12 |
Purdue Pharmaceutical Products L.P. |
Hodgkin lymphoma therapy
|
|
US11266631B2
(en)
|
2016-10-11 |
2022-03-08 |
Purdue Pharmaceutical Products L.P. |
Hodgkin lymphoma therapy
|
|
GB201709402D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating t-pll
|
|
GB201709403D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating sarcoma
|
|
GB201709406D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro-Cletique S A |
Compounds for treating TNBC
|
|
GB201709405D0
(en)
|
2017-06-13 |
2017-07-26 |
Euro Celtique Sa |
Compounds for treating ovarian cancer
|
|
WO2020128913A1
(en)
|
2018-12-18 |
2020-06-25 |
Mundipharma International Corporation Limited |
Compounds for treating multiple myeloma
|